| Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2 IM Shamkh, D Pratiwi Journal of Molecular Docking 1 (1), 1-14, 2021 | 6 | 2021 |
| Suitable Docking Protocol for the Design of Novel Coumarin Derivatives with Selective MAO-B Effects EV Mateev, I Valkova, M Georgieva, A Zlatkov Journal of Molecular Docking 1 (1), 40-47, 2021 | 4 | 2021 |
| Molecular Docking Studies of Spirostans as MAPK14 (P38α) Inhibitors and Their Potential Use against Cancer GN Lopez-Castillo, V Alatriste, J Sandoval-Ramírez, F Luna, ... Journal of Molecular Docking 1 (2), 59-67, 2021 | 3 | 2021 |
| The Study of Potential Antiviral Compounds from Indonesian Medicinal Plants as Anti-COVID-19 with Molecular Docking Approach BRP Rizma, AD Ananto, AL Sunarwidhi Journal of Molecular Docking 1 (1), 32-39, 2021 | 3 | 2021 |
| A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking A Mishra, R Waghela Journal of Molecular Docking 1 (1), 25-31, 2021 | 2 | 2021 |
| Homology Modeling and Molecular Docking Studies of Selected Substituted Tetradecane on vlsE Borrelia spielmanii V Paritala, H Thummala, TNS Mohith Journal of Molecular Docking 2 (1), 16-28, 2022 | 1 | 2022 |
| Molecular Docking Screening and Pharmacokinetic Studies of Some Boron-Pleuromutilin Analogues against Possible Targets of Wolbachia pipientis FA Ugbe, GA Shallangwa, A Uzairu, I Abdulkadir Journal of Molecular Docking 2 (1), 29-43, 2022 | 1 | 2022 |
| New Approach to create an Effective Natural Treatments of Infections caused by Human Papillomavirus M Dunjic, SG Turini, S Stanisic, N Sulovic, S Cvetkovic, D Mihajlovic, ... Journal of Molecular Docking 1 (2), 68-77, 2021 | 1 | 2021 |
| In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins IM Shamkh, D Pratiwi, HS Omar, NEHA Reyad Journal of Molecular Docking 1 (2), 49-58, 2021 | 1 | 2021 |
| Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2 LK Selvaraj, G Thayumanavan, S Jeyabalan, SL Jabaris Journal of Molecular Docking 1 (1), 15-24, 2021 | 1 | 2021 |
| Comparative In-Silico Molecular Docking of Silymarin for SARS-CoV-2 Receptor MASAG Arasi, S Ravichandran, I Iayaraman Journal of Molecular Docking 2 (1), 2022 | | 2022 |
| In Silico Approach: Effect of the Oxidation Iron State (Heme-Group) in Steroidogenesis Pathways D Mora-Martinez, J Organista-Nava, J Sandoval-Ramirez, ... Journal of Molecular Docking 2 (1), 44-57, 2022 | | 2022 |
| Pharmacophore Based Virtual Screening and Docking of Different Aryl Sulfonamide Derivatives of 5HT7R Antagonist N Fatema, V Manga, L Yamini, SA Khan, Q Ullah Journal of Molecular Docking 2 (1), 1-15, 2022 | | 2022 |
| In Silico Anti-Inflammation Prediction of Glycyrrhiza Extracts Against Covid-19 M Nazari Journal of Molecular Docking 1 (2), 84-90, 2021 | | 2021 |
| Corrigendum to" Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2”[J Mol Docking. 2021; 1 (2): 1-14] IM Shamkh, D Pratiwi, HS Omar Journal of Molecular Docking 1 (2), 48, 2021 | | 2021 |
Israa M ShamkhChemo and Bioinformatics Lab, Bio Search Research Institution, BSRI, Giza 12613, EgyptVerified email at std.agr.cu.edu.eg
